Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 1
2012 2
2013 1
2015 3
2016 1
2020 3
2021 2
2023 1
2024 2
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial.
Ghanei M, Ghalebaghi B, Sami R, Torabizadeh M, Mirsadraee M, Amra B, Tavakol M, Raji H, Fallahpour M, Kiani A, Abedini A, Jabbari Azad F, Mahdaviani SA, Attaran D, Samet M, Tavana S, Haddadzadeh Shoushtari M, Nazari J, AghaeiMeybodi F, Fazlollahi MR, Ghasemi R, Sabzvari A, Kafi H, Idani E. Ghanei M, et al. Among authors: tavana s. Front Immunol. 2024 Jul 29;15:1425906. doi: 10.3389/fimmu.2024.1425906. eCollection 2024. Front Immunol. 2024. PMID: 39136011 Free PMC article. Clinical Trial.
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.
Ansarin K, Attaran D, Jamaati H, Masjedi MR, Abtahi H, Alavi A, Aliyali M, Asnaashari AM, Farid-Hosseini R, Ghayumi SM, Ghobadi H, Ghotb A, Halvani A, Nemati A, Rahimi Rad MH, Rahimian M, Sami R, Sohrabpour H, Tavana S, Torabi-Nami M, Vahedi P. Ansarin K, et al. Among authors: tavana s. Tanaffos. 2015;14(2):73-94. Tanaffos. 2015. PMID: 26528362 Free PMC article. Review.
The Effect of Exogenous Surfactant on Moderate and Severe Stages of COVID-19 Induced ARDS: the Pilot Study of a Clinical Trial.
Fani K, Ghahremani M, Fathi M, Massoudi N, Tavana S, Nooraee N, Malekpour Alamdari N, Besharat S, Najafi Abrandabadi A, Pirsalehi A, Khabiri Khatiri MA, Amini Pouya M, Rajaei S, Dabbagh A. Fani K, et al. Among authors: tavana s. Iran J Pharm Res. 2021 Summer;20(3):553-559. doi: 10.22037/ijpr.2021.115390.15347. Iran J Pharm Res. 2021. PMID: 34904008 Free PMC article.
Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety.
Tavana S, Argani H, Gholamin S, Razavi SM, Keshtkar-Jahromi M, Talebian AS, Moghaddam KG, Sepehri Z, Azad TM, Keshtkar-Jahromi M. Tavana S, et al. Influenza Other Respir Viruses. 2012 Mar;6(2):136-41. doi: 10.1111/j.1750-2659.2011.00290.x. Epub 2011 Sep 28. Influenza Other Respir Viruses. 2012. PMID: 21955954 Free PMC article. Clinical Trial.
18 results